Living by numbers The Journal of Thoracic and Cardiovascular Surgery

Slides:

Advertisements

Similar presentations

The “occasional open heart surgeon” revisited

Advertisements

Society of Thoracic Surgeons 2008 cardiac risk models predict in-hospital mortality of heart valve surgery in a Chinese population: A multicenter study

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Two decades of pediatric lung transplant in the United States: Have we improved? Farhan Zafar, MD, Jeffrey S. Heinle, MD, Marc G. Schecter, MD, Joseph.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Extracorporeal membrane oxygenation as a bridge to lung transplantation is about more than just surviving Dirk Van Raemdonck, MD, PhD, Fabienne Dobbels,

Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures J. Saravana Ganesh, FRCS, Chris.

“Lead from the front”: Participative leadership

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation Arman Kilic, MD,

Toronto bridges to successful lung transplantation

Ground glass opacity of the lung: The veil that needs lifting

Right internal thoracic artery or saphenous vein grafting

Intrinsic cardiac stem cells are essential for regeneration

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Abracadabra I, II…HeartMate 3?

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

Application of a neuroscience research model to study neuroprotection in children with congenital heart disease Nobuyuki Ishibashi, MD, Richard A. Jonas,

Multilevel data analysis: What? Why? How?

Marye J. Gleva, MD, Charles B. Huddleston, MD

Go on-pump or off-pump in diabetic patients?

Should lung transplantation be performed using donation after cardiac death? The United States experience David P. Mason, MD, Lucy Thuita, MS, Joan M.

The lord of the rings Antonio Miceli, MD, PhD

Impact of prior hospital mortality versus surgical volume on mortality following surgery for congenital heart disease Matthew E. Oster, MD, Matthew J.

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Juan N. Pulido, MD The Journal of Thoracic and Cardiovascular Surgery

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Bartley P. Griffith, MD, FACS, FRCS

Experience from an American Association for Thoracic Surgery Foundation for Thoracic Surgery Training Fellowship: Lung transplantation in Toronto General.

Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality Christopher M. Pezzi, MD, Katherine Mallin, PhD, Andres Samayoa.

A first start for lung transplantation?

Get it right the first time

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Impact of low donor to recipient weight ratios on cardiac transplantation Senthil Nathan Jayarajan, MD, Sharven Taghavi, MD, Eugene Komaroff, PhD, Abeel.

Historical perspectives of The American Association for Thoracic Surgery: Robert M. Janes, MD ( ) Myunghyun Lee, MD, Vivek Rao, MD, PhD The.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Niv Ad, MD, Lawrence M. Wei, MD

Long-term survival in lung transplant recipients after successful preoperative coronary revascularization Leonardo Seoane, MD, Lee M. Arcement, MD, Vincent.

A fate worse than death Jennifer S. Lawton, MD

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Commentary: Do the right thing! Ethical versus legal

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

The thoracoabdominal saga and heroes

The harder one looks, the more one finds

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

The continuing challenge of congenital heart disease in China

The Journal of Thoracic and Cardiovascular Surgery

Between a rock and a hard place

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

Heidi Goerler, MD, Andre Simon, MD, Gregor Warnecke, MD, Anna L

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

“The more things change…”: The challenges ahead

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Apples remain apples NO matter what

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

The evolution of cardiothoracic critical care

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks! W. Hampton Gray, MD, P. Michael.

Calpain inhibitors: The aspirin of the 21st century?

Presentation transcript:

Living by numbers The Journal of Thoracic and Cardiovascular Surgery Dirk Van Raemdonck, MD, PhD, Arne Neyrinck, MD, PhD, Robin Vos, MD, PhD, Geert M. Verleden, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 156, Issue 2, Pages 906-907 (August 2018) DOI: 10.1016/j.jtcvs.2018.04.002 Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 A, Evolution in annual number and transplant type of more than 1000 lung transplants performed at the University Hospitals Leuven, Belgium between July 14, 1991, and December 31, 2017. B, Overall lung transplant (LTx) graft survival (censored at redo lung transplantation). UZ Leuven, Universitaire Ziekenhuizen Leuven (University Hospitals Leuven). C, Graft survival in the first 1000 lung transplant patients stratified per quartile. Results improved significantly with growing experience over time: quartile 1 versus quartile 4 (P < .0001; hazard ratio, 2.311; 95% confidence interval, 1.583-3.375); quartile 2 versus quartile 4 (P = .013; hazard ratio, 1.627; 95% confidence interval, 1.105-2.395); quartile 3 versus quartile 4 (P = .50; hazard ratio, 1.154; 95% confidence interval, 0.763-1.745). HL, Heart-lung transplant; DL, double-lung transplant; SL, single-lung transplant. The Journal of Thoracic and Cardiovascular Surgery 2018 156, 906-907DOI: (10.1016/j.jtcvs.2018.04.002) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

Fifteen hundred likes for the lung transplant group at Washington University in St Louis. The Journal of Thoracic and Cardiovascular Surgery 2018 156, 906-907DOI: (10.1016/j.jtcvs.2018.04.002) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions